Planning

Ustekinumab

  • NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

UK2: Preliminary market engagement notice - Procurement Act 2023 - view information about notice types

Notice identifier: 2025/S 000-083013

Procurement identifier (OCID): ocds-h6vhtk-05f601

Published 15 December 2025, 3:44pm



Scope

Reference

PHA-FTS-61334

Description

This is a contract for the provision of Ustekinumab for NHS sites in Wales

Total value (estimated)

  • £9,489,301 excluding VAT
  • £11,387,160 including VAT

Above the relevant threshold

Contract dates (estimated)

  • 1 October 2026 to 30 June 2028
  • Possible extension to 30 June 2029
  • 2 years, 9 months

Main procurement category

Goods

CPV classifications

  • 33600000 - Pharmaceutical products

Contract locations

  • UKL - Wales

Engagement

Engagement deadline

30 January 2026

Engagement process description

This notice is being issued to advise suppliers of a forthcoming opportunity that is due to be published by Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts).

There is no formal engagement process for this opportunity. Any suppliers who may like more information on this opportunity before the tender is published, please contact Caroline Cheng (Caroline.Cheng2@wales.nhs.uk)


Participation

Particular suitability

Small and medium-sized enterprises (SME)


Submission

Publication date of tender notice (estimated)

2 February 2026


Contracting authority

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

  • NHS Organisation Data Service: RQF

4-5 Charnwood Court,

Cardiff

CF14 3UZ

United Kingdom

Region: UKL22 - Cardiff and Vale of Glamorgan

Organisation type: Public authority - central government

Devolved regulations that apply: Wales